Zhengye Biotechnology Holding Ltd (ZYBT) Stock Analysis

Verdict: AVOID

Revenue contraction (-45% in 2 years) and crashing gross margins (8.3% TTM) render ZYBT's recent 50.4% surge a speculative micro-cap pump.

Investment score: 18/100

Analysis as of

Is Zhengye Biotechnology Holding Ltd stock worth reviewing? The TradeMates thesis

The TradeMates model assigns an AVOID rating to ZYBT due to collapsing top-line revenue, severe net losses, and extreme speculative volatility.

7-factor investment score

Zhengye Biotechnology Holding Ltd opportunities and risks

What speaks for ZYBT

What speaks against ZYBT

Frequently asked questions about Zhengye Biotechnology Holding Ltd (ZYBT)

Is ZYBT stock a good investment?

The TradeMates model rates Zhengye Biotechnology Holding Ltd as AVOID with an investment score of 18/100. The TradeMates model assigns an AVOID rating to ZYBT due to collapsing top-line revenue, severe net losses, and extreme speculative volatility. This is algorithmic model output, not personal investment advice.

Is ZYBT stock a buy?

The TradeMates model verdict for ZYBT is AVOID with an investment score of 18/100. Treat this as a model signal to review, not a personal buy recommendation.